Clinical Social Workers in Dillon, MT Accepting Medicare

9 Clinical Social Workers found. Showing 1 - 9

Jacqueline Foster Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 67 Ryan Canyon Ln, Dillon, MT 59725 Phone: 406-683-6219

Valerie Coulter, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 212 E Bannack St, Dillon, MT 59725 Phone: 406-241-1099

Ms. Wanda Ethel Jensen, SWLC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3525 Mt Highway 91 N Trlr 15, Dillon, MT 59725 Phone: 406-660-0904

Amy Wellborn Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 30 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-1188

Fredrick John Morganthaler Ii, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 610 N Montana St, Dillon, MT 59725 Phone: 406-683-4013

Haley Hickock, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 236 E Reeder St, Dillon, MT 59725 Phone: 406-683-6106

Jenny Ann Given, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 600 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3000

Ms. Jeanette Prodgers, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 610 Monroe Ave, Dillon, MT 59725 Phone: 406-865-0381

Mr. James G. Sommers, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 234 E Reeder St, Dillon, MT 59725 Phone: 406-683-2200    Fax: 406-683-4168

News Archive

immatics biotechnologies closes €34 million Series D financing round

immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced multi-peptide cancer vaccines that are active against cancer, today announced that it has closed a €34 million Series D financing round.

New study suggests that e-cigarette vapors can damage lungs

Do electronic cigarettes help people quit smoking? As the debate continues on that point, a new University of Rochester study suggests that e-cigarettes are likely a toxic replacement for tobacco products.

Novel SARS-CoV-2 variants partially resistant to infection- and vaccine-induced immunity, study finds

A recent study conducted by a team of scientists in the Netherlands has revealed that while severely affected hospitalized COVID-19 patients and vaccinated individuals are capable of neutralizing the B.1.1.7, B.1.351, and P.1 variants of SARS-CoV-2, a significant proportion of non-hospitalized patients with less severe COVID-19 remain susceptible to these viral variants.

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

Study sheds light on mechanism of empty memories in epileptic patients

Between seizures and continually, brain cells in epileptic patients send signals that make "empty memories," perhaps explaining the learning problems faced by up to 40 percent of patients. This is the finding of a study in rats and humans led by researchers at NYU Langone Medical Center and published April 25 in Nature Medicine.

Read more Medical News

› Verified 8 days ago